Applied Materials, Inc. vs Lam Research Corporation — Stock Comparison
Q·Score Breakdown
8.1
Buy
Overall
8.6
Strong Buy
Quality
Health
Growth
Valuation
Sentiment
AMAT
Clean balance sheet with low leverage (0.3× debt-to-equity).
LRCX
Earnings growing 41% year-over-year on 24% revenue growth.
Analyst Consensus
BUY
Target $424.38 (+10.0%)
32 analysts
BUY
Target $307.74 (+23.0%)
31 analysts
Fundamentals
AMAT
LRCX
39.5×
Trailing P/E
47.2×
27.4×
Forward P/E
32.0×
27.8%
Profit Margin
30.9%
48.7%
Gross Margin
50.0%
38.9%
ROE
66.8%
-2.1%
Revenue Growth
23.8%
75.2%
Earnings Growth
40.8%
1.64
Beta
1.79
—
Price / Book
—
$306.1B
Market Cap
$313.0B
$149 – $421
52-Week Range
$71 – $276
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.